CSF1R and central nervous system cancer: Similarly, Pyonteck and coworkers used a BBB-penetrant colony stimulating factor-1 receptor (CSF-1R) inhibitor BLZ945 with an IC50 of 1 nM to reprogram macrophages into the inflammatory M1 state and block mouse glioma progression [62].